2-Chloro-3-methoxypyrazine

Catalog No. :
ACMHEW657
CAS No. :
40155-28-0
Molecular Formula :
C5H5ClN2O
Molecular Weight :
144.56

IUPAC Name:2-chloro-3-methoxypyrazine

2-Chloro-3-methoxypyrazine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g98%$57.00Login to see priceIn stockIn stock
100g98%$205.00Login to see priceIn stockIn stock
500g98%$984.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Chloro-3-methoxypyrazine
IUPAC Name2-chloro-3-methoxypyrazine
MDL No.MFCD02684324
Molecular FormulaC5H5ClN2O
Molecular Weight144.56
SMILESClC1=NC=CN=C1OC
InChI KeyPUMFABSDZOUISK-UHFFFAOYSA-N
Synonym2-Chloro-3-methoxypyrazine | 40155-28-0 | 2-chloro-3-methoxy-pyrazine | MFCD02684324 | Pyrazine, 2-chloro-3-methoxy- | 2-methoxy-3-chloro-pyrazine | SCHEMBL725143 | DTXSID80473011 | PUMFABSDZOUISK-UHFFFAOYSA-N | AKOS010967030 | AC-8789 | CS-W019381 | MB02506 | PS-5653 | 2-Chloro-3-m
CAS No.40155-28-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACMHEW657 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  2. Plus
  3. ACQULK639 route compound structure diagram
    ACQULK6394858-85-9 In Stock
  4. Then
  5. ACMHEW657 route product structure diagram
    ACMHEW65740155-28-0 In Stock
Inquiry

2. ACMHEW657 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACSUQJ564 route compound structure diagram
    ACSUQJ5645882-45-1 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACMHEW657 route product structure diagram
    ACMHEW65740155-28-0 In Stock
Inquiry

Comments (0)